Descrizione del progetto
Un software pre-operatorio basato sull’IA
Di frequente, gli interventi alle ossa richiedono l’uso di materiali protesici per ottenere un risultato efficiente ed efficace. Pertanto, i chirurghi ortopedici devono misurare con elevata precisione le distanze, gli angoli e la profondità delle ossa fratturate. Il software sviluppato dal progetto BSPA, finanziato dall’UE, impiega l’IA per annotare, segmentare e visualizzare precisamente le fratture ossee in 3D, fornendo nell’arco di pochi minuti una definizione automatizzata dei parametri principali necessari alla chirurgia ossea. Il software del progetto BSPA è già stato installato in alcuni ospedali e l’obiettivo è offrire il 98 % della precisione nel processo a una frazione del costo. Durante la fase di fattibilità, i partner del progetto hanno stabilito una tabella di marcia per ottenere l’approvazione normativa, valutando inoltre potenziali partenariati per future prospettive di commercializzazione.
Obiettivo
Healthplus.ai has developed a Proof-of-Concept version (TRL level 3) of an Artificial Intelligence (AI) tool to be offered as a Software as a Service (SaaS) solution and able to automatically and very precisely annotate, segment and 3D visualize unique bone and fracture patient cases (goal is >98% accuracy compared to 90-92 with current solutions), within minutes (instead of hours to days), and at a fraction of current cost (€10 vs €1,200). This process will hence also enable automated and expedient determination to do exact measurements of distances, angles, depths, and making a list of required prosthetic materials to perform the bone operation as efficient and effective as possible. We are currently already partnered with several Dutch hospitals and a small number of internationally renowned institutions.
Focus in this feasibility phase will be put on in-depth market study with/on end-users (key stakeholders) and the legal framework surrounding the innovation and future implementation within European hospitals. Also market sizes will be calculated further, a roadmap to regulatory approval set up, purchase (department) procedures per country worked out, and pricing strategy set after clear cost and value assessment. Various international partnerships will be assessed to accelerate the project and enhance its impact via well-established companies in the medical imaging technology workflow (Siemens, SECTRA, Phillips, Envoy.ai et cetera).
An important part of the study will address orthopedic device manufacturers. We will assess the possibility to extent our business model to create a second-side to the marketplace; As orthopedic device makers spend approximately 36% on marketing and sales (almost 11B USD in 2017 for the top ten manufacturers)
Campo scientifico
- natural sciencescomputer and information sciencesartificial intelligence
- medical and health sciencesclinical medicinesurgery
- engineering and technologymedical engineeringdiagnostic imagingcomputed tomography
- engineering and technologymechanical engineeringmanufacturing engineeringadditive manufacturing
- natural sciencesmathematicsapplied mathematicsmathematical model
Programma(i)
Argomento(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-SMEInst-2018-2020-1
Meccanismo di finanziamento
SME-1 - SME instrument phase 1Coordinatore
1017 AZ AMSTERDAM
Paesi Bassi
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.